SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-002331
Filing Date
2024-01-16
Accepted
2024-01-16 07:00:32
Documents
45
Period of Report
2023-11-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 624735
2 ex31-1.htm EX-31.1 8354
3 ex31-2.htm EX-31.2 8873
4 ex32-1.htm EX-32.1 4165
5 ex32-2.htm EX-32.2 3939
  Complete submission text file 0001493152-24-002331.txt   3520262

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bmra-20231130.xsd EX-101.SCH 20857
7 XBRL CALCULATION FILE bmra-20231130_cal.xml EX-101.CAL 45180
8 XBRL DEFINITION FILE bmra-20231130_def.xml EX-101.DEF 94198
9 XBRL LABEL FILE bmra-20231130_lab.xml EX-101.LAB 234717
10 XBRL PRESENTATION FILE bmra-20231130_pre.xml EX-101.PRE 177583
39 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 488804
Mailing Address 17571 VON KARMAN AVENUE IRVINE CA 92614
Business Address 17571 VON KARMAN AVENUE IRVINE CA 92614 9493792875
BIOMERICA INC (Filer) CIK: 0000073290 (see all company filings)

IRS No.: 952645573 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 001-37863 | Film No.: 24533614
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)